Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Serplulimab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT04547166
What this trial is testing

A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
Shanghai Henlius Biotech 568
Testing effectiveness (Phase 2)Active Not RecruitingNCT05831891
What this trial is testing

Fruquintinib Plus Serplulimab as First-Line Therapy for Metastatic Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Non-clear Cell Renal Cell Carcinoma
RenJi Hospital 40
Testing effectiveness (Phase 2)UnknownNCT05641493
What this trial is testing

A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of HLX208+HLX10 in NSCLC With BRAF V600E Mutation

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Henlius Biotech 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07466303
What this trial is testing

Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer

Who this might be right for
Breast CancerSerplulimab Combined With SHR-A1811 as Neoadjuvant Therapy for Triple-Negative Breast Cancer
Xijing Hospital 84
Testing effectiveness (Phase 2)UnknownNCT06334757
What this trial is testing

Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment Failure

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Henan Cancer Hospital 46
Testing effectiveness (Phase 2)Looking for participantsNCT07647094
What this trial is testing

A Prospective, Multicenter, Randomized Controlled Study on the Efficacy and Safety of Low-dose Carboplatin Combined With Nab-Paclitaxel and Delayed Administration of Serplulimab as First-line Treatment for Advanced Squamous Non-small Cell Lung Cancer

Who this might be right for
NSCLC
People's Hospital of Quzhou 112
Testing effectiveness (Phase 2)Looking for participantsNCT06860529
What this trial is testing

Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast Cancer

Who this might be right for
HR+/HER2- Breast Cancer
Henan Cancer Hospital 357
Testing effectiveness (Phase 2)Looking for participantsNCT07583511
What this trial is testing

Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study

Who this might be right for
Small-cell Lung Cancer
Sun Yat-sen University 90
Not applicableNot Yet RecruitingNCT06156332
What this trial is testing

Surufatinib Combined With Serplulimab in the Treatment of Advanced Solid Tumors With Neuroendocrine Differentiation That Failed Standard Therapy

Who this might be right for
Advanced Solid Tumors With Neuroendocrine Differentiation
Shanghai Changzheng Hospital 39
Testing effectiveness (Phase 2)UnknownNCT05882630
What this trial is testing

Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Fujian Cancer Hospital 39
Testing effectiveness (Phase 2)UnknownNCT05444374
What this trial is testing

A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Sichuan Cancer Hospital and Research Institute 48
Testing effectiveness (Phase 2)Looking for participantsNCT05742425
What this trial is testing

Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal Metastases

Who this might be right for
Unresectable Colon Cancer Peritoneal MetastasesPMMR/Ras/BRAF Wild-type
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Testing effectiveness (Phase 2)UnknownNCT05675033
What this trial is testing

Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma

Who this might be right for
Lung AdenocarcinomaStage IV Non-small Cell Lung CancerPD-1 Inhibitor+1 more
Fujian Cancer Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT05837052
What this trial is testing

A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy as Conversion Therapy in NSCLC

Who this might be right for
Unresectable Lung Non-Small Cell Carcinoma
Zhejiang University 49
Testing effectiveness (Phase 2)Looking for participantsNCT07604909
What this trial is testing

A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant Chemotherapy

Who this might be right for
Colorectal CancerRelapse
Fudan University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07708285
What this trial is testing

Luvometinib in Combination With Serplulimab for NF2-Related Tumors

Who this might be right for
NF2-related SchwannomatosisNF2Neurofibromatosis Type 2+2 more
Beijing Tiantan Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05872685
What this trial is testing

Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05)

Who this might be right for
Adenocarcinoma of the StomachAdenocarcinoma of Esophagogastric JunctionProficient Mismatch Repair
Yu jiren 314
Post-approval studies (Phase 4)Not Yet RecruitingNCT06388135
What this trial is testing

Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Yang Jianjun, PhD 80
Not applicableUnknownNCT05873790
What this trial is testing

Minimal Residual Disease Dynamic Monitoring in First-Line Serplulimab Plus Chemotherapy in Treatment of Extensive Small Cell Lung Cancer: An Observational Study

Who this might be right for
Lung Cancer
The First Hospital of Jilin University 30
Testing effectiveness (Phase 2)UnknownNCT06496789
What this trial is testing

Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer

Who this might be right for
Gastric Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 35
Next Page